BARD1 Gene Breast Cancer Susceptibility NGS Genetic DNA Test
Comprehensive Genetic Testing for Hereditary Breast Cancer Risk
The BARD1 Gene Breast Cancer Susceptibility NGS Genetic DNA Test represents a breakthrough in personalized cancer risk assessment. This advanced genetic screening utilizes cutting-edge Next-Generation Sequencing (NGS) technology to detect mutations in the BARD1 gene, which plays a crucial role in DNA repair and tumor suppression. Understanding your genetic predisposition to breast cancer empowers you to take proactive measures for early detection and prevention.
What Does the BARD1 Gene Test Measure?
This comprehensive genetic analysis specifically targets the BARD1 (BRCA1 Associated RING Domain 1) gene, which functions as a tumor suppressor and collaborates with BRCA1 in DNA damage repair pathways. The test detects:
- Pathogenic variants and mutations in the BARD1 gene
- Single nucleotide polymorphisms (SNPs) associated with increased cancer risk
- Copy number variations affecting gene function
- Deleterious mutations that disrupt protein function
Who Should Consider BARD1 Genetic Testing?
This test is particularly recommended for individuals with:
- Personal history of breast cancer diagnosed before age 50
- Family history of multiple breast cancer cases
- Relatives with known BARD1 or BRCA mutations
- Bilateral breast cancer or multiple primary cancers
- Male breast cancer in the family
- Ashkenazi Jewish ancestry with breast cancer history
- Family members with ovarian, pancreatic, or prostate cancer
Key Benefits of BARD1 Genetic Testing
- Early Risk Identification: Detect hereditary cancer predisposition before disease development
- Personalized Prevention: Tailor screening and prevention strategies based on genetic risk
- Family Planning Guidance: Make informed reproductive decisions
- Proactive Medical Management: Implement enhanced surveillance protocols
- Peace of Mind: Reduce uncertainty about hereditary cancer risk
Understanding Your Test Results
Your BARD1 genetic test results will fall into one of three categories:
- Positive Result: A pathogenic mutation was detected, indicating increased cancer risk. Our genetic counselors will provide comprehensive risk management recommendations.
- Negative Result: No known pathogenic mutations were found, though this doesn’t eliminate all cancer risk. General population screening guidelines apply.
- Variant of Uncertain Significance (VUS): A genetic change was found, but its clinical significance is unknown. Regular follow-up and family studies may be recommended.
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We have diagnostic centers conveniently located across the United States, including major metropolitan areas such as New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our state-of-the-art facilities ensure consistent, high-quality testing standards nationwide.
Take Control of Your Health Today
Don’t wait to understand your hereditary cancer risk. Our comprehensive BARD1 genetic testing provides the clarity you need to make informed health decisions. Schedule your appointment today by calling our dedicated genetic counseling team at +1(267) 388-9828 or book your test online through our secure patient portal.
Turnaround Time: 3-4 Weeks
Sample Type: Blood, Extracted DNA, or One Drop Blood on FTA Card
Pre-Test Requirements: Clinical history documentation and genetic counseling session to create family pedigree chart
